{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:09:26Z","timestamp":1740107366017,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K11320","16K20313"],"award-info":[{"award-number":["16K11320","16K20313"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chukyo Longevity Medical and Promotion Foundation"},{"DOI":"10.13039\/501100006680","name":"Takeda Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00417-016-3468-x","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T14:51:35Z","timestamp":1471531895000},"page":"449-455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Short-term focal macular electroretinogram of eyes treated by aflibercept & photodynamic therapy for polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"255","author":[{"given":"Kei","family":"Takayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piao","family":"Chang-Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"3468_CR1","first-page":"39","volume":"317","author":"G Coppens","year":"2011","unstructured":"Coppens G, Spielberg L, Leys A (2011) Polypoidal choroidal vasculopathy, diagnosis and management. Bull Soc Belge Ophtalmol 317:39\u201344","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"3468_CR2","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1111\/j.1755-3768.2009.01850.x","volume":"88","author":"A Okubo","year":"2010","unstructured":"Okubo A, Arimura N, Abematsu N, Sakamoto T (2010) Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes. Acta Ophthalmol 88:e107\u2013e114","journal-title":"Acta Ophthalmol"},{"key":"3468_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.preteyeres.2013.09.003","volume":"37","author":"P Nowak-Sliwinska","year":"2013","unstructured":"Nowak-Sliwinska P, van den Bergh H, Sickenberg M, Koh AH (2013) Photodynamic therapy for polypoidal choroidal vasculopathy. Prog Retin Eye Res 37:182\u2013199","journal-title":"Prog Retin Eye Res"},{"key":"3468_CR4","first-page":"359","volume":"8","author":"RL Wong","year":"2013","unstructured":"Wong RL, Lai TY (2013) Polypoidal choroidal vasculopathy: an update on therapeutic approaches. J Ophthalmic Nurs Technol 8:359\u2013371","journal-title":"J Ophthalmic Nurs Technol"},{"key":"3468_CR5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/IAE.0b013e31820d3f3f","volume":"31","author":"TY Lai","year":"2011","unstructured":"Lai TY, Lee GK, Luk FO, Lam DS (2011) Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Retina 31:1581\u20131588","journal-title":"Retina"},{"key":"3468_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110667","volume":"9","author":"W Wang","year":"2014","unstructured":"Wang W, He M, Zhang X (2014) Combined intravitreal anti-VEGF and photodynamic therapy versus photodynamic monotherapy for polypoidal choroidal vasculopathy: a systematic review and meta-analysis of comparative studies. PLoS One 9, e110667","journal-title":"PLoS One"},{"key":"3468_CR7","first-page":"1123","volume":"27","author":"WH Seiple","year":"1986","unstructured":"Seiple WH, Siegel IM, Carr RE, Mayron C (1986) Evaluating macular function using the focal ERG. Invest Ophthalmol Vis Sci 27:1123\u20131130","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3468_CR8","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1167\/iovs.08-1835","volume":"49","author":"H Nishihara","year":"2008","unstructured":"Nishihara H, Kondo M, Ishikawa K, Sugita T, Piao CH, Nakamura Y, Terasaki H (2008) Focal macular electroretinograms in eyes with wet-type age-related macular degeneration. Invest Ophthalmol Vis Sci 49:3121\u20133125","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3468_CR9","first-page":"1","volume":"64","author":"H Terasaki","year":"2001","unstructured":"Terasaki H (2001) Rescue of retinal function by macular translocation surgery in age-related macular degeneration and other diseases with subfoveal choroidal neovascularization. Nagoya J Med Sci 64:1\u20139","journal-title":"Nagoya J Med Sci"},{"key":"3468_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0420.2005.00529.x","volume":"84","author":"E Pirozzi","year":"2006","unstructured":"Pirozzi E, Manganelli C, Piccardi M, Minnella A, Fadda A, Ziccardi L, Coccimiglio F, Falsini B (2006) Retinal function following transpupillary thermotherapy for occult choroidal neovascularization in age-related macular degeneration: a short-term study by focal electroretinography. Acta Ophthalmol Scand 84:27\u201335","journal-title":"Acta Ophthalmol Scand"},{"key":"3468_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1097\/IAE.0b013e31819c631a","volume":"29","author":"K Ishikawa","year":"2009","unstructured":"Ishikawa K, Nishihara H, Ozawa S, Piao CH, Ito Y, Kondo M, Terasaki H (2009) Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide. Retina 29:803\u2013810","journal-title":"Retina"},{"key":"3468_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00417-010-1548-x","volume":"249","author":"K Ishikawa","year":"2011","unstructured":"Ishikawa K, Nishihara H, Ozawa S, Piao CH, Ito Y, Kondo M, Terasaki H (2011) Focal macular electroretinograms after photodynamic therapy combined with intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 249:273\u2013280","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3468_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ajo.2012.04.020","volume":"154","author":"DJ Browning","year":"2012","unstructured":"Browning DJ, Kaiser PK, Rosenfeld PJ, Stewart MW (2012) Aflibercept for age-related macular degeneration: a game-changer or quiet addition? Am J Ophthalmol 154:222\u2013226","journal-title":"Am J Ophthalmol"},{"key":"3468_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/bjophthalmol-2014-306432","volume":"99","author":"H Koizumi","year":"2015","unstructured":"Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2015) Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study. Br J Ophthalmol 99:1284\u20131288","journal-title":"Br J Ophthalmol"},{"key":"3468_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.survophthal.2003.10.007","volume":"49","author":"AP Ciardella","year":"2004","unstructured":"Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA (2004) Polypoidal choroidal vasculopathy. Surv Ophthalmol 49:25\u201337","journal-title":"Surv Ophthalmol"},{"key":"3468_CR16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Group ToA-rMDWPTTS","year":"1999","unstructured":"Group ToA-rMDWPTTS (1999) Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Arch Ophthalmol 117:1329\u20131345","journal-title":"Arch Ophthalmol"},{"key":"3468_CR17","first-page":"1743","volume":"30","author":"Y Miyake","year":"1989","unstructured":"Miyake Y, Shiroyama N, Horiguchi M, Ota I (1989) Asymmetry of focal ERG in human macular region. Invest Ophthalmol Vis Sci 30:1743\u20131749","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3468_CR18","first-page":"1631","volume":"29","author":"Y Miyake","year":"1988","unstructured":"Miyake Y, Shiroyama N, Ota I, Horiguchi M (1988) Oscillatory potentials in electroretinograms of the human macular region. Invest Ophthalmol Vis Sci 29:1631\u20131635","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3468_CR19","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32:1453\u20131464","journal-title":"Retina"},{"key":"3468_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000329466","volume":"226","author":"MH Song","year":"2011","unstructured":"Song MH, Ryu HW, Roh YJ (2011) One-year results of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy. Ophthalmologica 226:119\u2013126","journal-title":"Ophthalmologica"},{"key":"3468_CR21","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1167\/iovs.06-1277","volume":"48","author":"K Ishikawa","year":"2007","unstructured":"Ishikawa K, Kondo M, Ito Y, Kikuchi M, Nishihara H, Piao CH, Sugita T, Terasaki H (2007) Correlation between focal macular electroretinograms and angiographic findings after photodynamic therapy. Invest Ophthalmol Vis Sci 48:2254\u20132259","journal-title":"Invest Ophthalmol Vis Sci"},{"unstructured":"Kim H, Lee SC, Kwon KY, Lee JH, Koh HJ, Byeon SH, Kim SS, Kim M, Lee CS (2015) Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch. Clin. Exp. Ophthalmol pp1-7","key":"3468_CR22"},{"key":"3468_CR23","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ajo.2013.03.041","volume":"156","author":"I Maruko","year":"2013","unstructured":"Maruko I, Iida T, Oyamada H, Sugano Y, Ojima A, Sekiryu T (2013) Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy. Am J Ophthalmol 156:548\u2013556","journal-title":"Am J Ophthalmol"},{"issue":"594\u2013603","key":"3468_CR24","volume":"151","author":"I Maruko","year":"2011","unstructured":"Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T (2011) Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 151(594\u2013603), e1","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3468-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3468-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3468-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:08:42Z","timestamp":1589634522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3468-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3468"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3468-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2016,8,18]]},"assertion":[{"value":"16 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This work was partially supported by Grants-in-Aid for Scientific Research B (H.T.; 15H04994), Grant-in-Aid for Scientific Research C (S.U.; 16\u00a0K11320), Grant-in-Aid for Young Scientists B (K.K.; 16\u00a0K20313), Chukyo Longevity Medical and Promotion Foundation (H.K.), Takeda Medical Research Foundation (H.K.). These sponsors had no role in the design or conduct of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"H. Terasaki received personal fees from Bayer HealthCare, Novartis, Santen, Wakamoto, and Pfizer. H. Terasaki received research funding from Novartis, Santen, Wakamoto, and Pfizer.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosures"}},{"value":"H. Terasaki had Grants-in-Aid for Scientific Research B (15H04994) and received personal fees from Bayer HealthCare, Novartis, Santen, Wakamoto, and Pfizer. H. Terasaki received research funding from Novartis, Santen, Wakamoto, and Pfizer.S. Ueno had Grant-in-Aid for Scientific Research C (16\u00a0K11320). K, Kataoka had Grant-in-Aid for Young Scientists B (16\u00a0K20313). H. Kaneko had financial support from Chukyo longevity medical and promotion foundation, and Takeda Medical Research Foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The procedures performed in the study were in accordance with the ethical standards of the Nagoya University Hospital Ethics Review Board and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Nagoya University Hospital Ethics Review Board approved this retrospective analysis of patient data. For this type of study, formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}